086450.KQ Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:30):

Stats
Šios dienos apimtis	99 170.00
Vidutinė apimtis	192 704
Rinkos kapitalizacija	703.20B
EPS	KRW0 ( 2024-03-14 )
Kita pelno data	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW12.28 (0.07%)

Tūris Koreliacija

Ilgas: 0.29 (neutral)

Trumpas: 0.77 (moderate)

Signal:(64.775) Neutral

DongKook Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

DongKook Pharmaceutical Koreliacija - Valiuta/Žaliavos

0.26
( neutral )

-0.02
( neutral )

0.34
( neutral )

0.29
( neutral )

0.03
( neutral )

DongKook Pharmaceutical Finansinės ataskaitos

Annual	2023
Pajamos:	KRW730.99B
Bruto pelnas:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

FY	2023
Pajamos:	KRW730.99B
Bruto pelnas:	KRW405.04B (55.41 %)
EPS:	KRW1 073.13

FY	2022
Pajamos:	KRW661.65B
Bruto pelnas:	KRW375.19B (56.71 %)
EPS:	KRW1 203.46

Financial Reports:

No articles found.

DongKook Pharmaceutical

DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.